GE strengthens "upstream" bioprocessing capabilities with PAA purchase
This article was originally published in Clinica
Executive Summary
GE Healthcare has increased its presence in the biomedical research and manufacturing industries by agreeing to acquire PAA Laboratories, a privately-held developer and supplier of cell culture media. Financial terms of the deal, which is expected to close in the third quarter, were not disclosed.